Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in rats

Drug Metabolism and Disposition

Volumn 32, Issue 8, 2004, Pages 786-793

  Williams, Marion L ^a   Mager, Donald E ^a   Parenteau, Heli ^c   Gudi, Girish ^d,e   Tracy, Timothy S ^d,f   Mulheran, Mike ^b   Wainer, Irving W ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DEHYDRONORKETAMINE; CYTOCHROME P450; DRUG METABOLITE; KETAMINE; NORKETAMINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; ENANTIOMER; GAS CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; RAT;

ANIMALS; KETAMINE; MALE; PROTEIN-ENERGY MALNUTRITION; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 3242705686     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.8.786     Document Type: Article

References (37)

1. Adams JD, Baillie TA, Trevor AJ, and Castagnoli N (1981) Studies of the biotransformation of ketamine. 1. Identification of metabolites produced in vitro from rat liver microsomal preparations. Biomed Mass Spectrom 8:527-538.
2. Anderson KE (1988) Influences of diet and nutrition on clinical pharmacokinetics. Clin Pharmacokinet 14:325-346.
3. Buchanan N, Davis MD, Henderson DB, Mucklow JC, and Rawlins MD (1980) Acetanilide pharmacokinetics in kwashiorkor. Br J Clin Pharmacol 9:525-526.
4. Buchanan N, Eyberg C, and Davis MD (1979a) Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor. Am J Clin Nutr 32:2439-2442.
5. Buchanan N, Eyberg C, and Davis MD (1979b) Isoniazid pharmacokinetics in kwashiorkor. S Afr Med J 56:299-300.
6. Campbell TC and Hayes JR (1974) Role of nutrition in the drug-metabolizing enzyme system. Pharmacol Rev 26:171-197.
7. Clements JA, Nimmo WS, and Grant IS (1982) Bioavailability, pharmacokinetics and analgesic activity of ketamine in humans. J Pharm Sci 71:539-541.
8. Cohen ML and Trevor AJ (1974) On the cerebral accumulation of ketamine and the relationship between metabolism of the drug and its pharmacological effects. J Pharmacol Exp Ther 189:351-358.
9. Cusack BJ, Young SP, Loseke VL, Hurty MR, Beals L, and Olsen RD (1992) Effect of low-protein diet on doxombicin pharmacokinetics in the rabbit. Cancer Chemother Pharmacol 30:145-148.
10. Domino EF, Zsigmond EK, Domino LE, Domino KE, Kothary SP, and Domino SE (1982) Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay. Anesth Analg 61:87-92.
11. Duvaldestin P (1981) Pharmacokinetics in intravenous anaesthetic practice. Clin Pharmacokinet 6:61-82.
12. Fernandez C, Parenteau H, Lloyd DK, and Wainer IW (1996) The influence of dietary protein deficiency on the microsomal metabolism of testosterone in the rat. Pharmacol Commun 7:221-227.
13. Granvil CP, Parenteau H, and Wainer IW (1994) The effect of protein-calorie malnutrition on ifosfamide metabolism. Clin Pharmacol Ther 55:140-140.
14. Greene JB (1988) Clinical approach to weight loss in the patient with HIV infection. Gastroenterol Clin North Am 17:573-586.
15. Hijazi Y and Boulieu R (2002) Contribution of CYP3A4, CYP2B6 and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 30:853-858.
16. Hong SC and Davisson JN (1982) Stereochemical studies of demethylated ketamine enantiomers. J Pharm Sci 71:912-914.
17. Jung D (1985) Disposition of acetaminophen in protein-calorie malnutrition. J Pharmacol Exp Ther 232:178-182.
18. Kaka JS and Hayton WL (1980) Pharmacokinetics of ketamine and two metabolites in the dog. J Pharmacokinet Biopharm 8:193-202.
19. Marietta MP, Way WL, Castagnoli N, and Trevor AJ (1977) On the pharmacology of the ketamine enantiomorphs in the rat. J Pharmacol Exp Ther 202:157-165.
20. Morley JE (1998) Protein-energy malnutrition in older subjects. Proc Nutr Soc 57:587-592.
21. Morris ME and Pang KS (1987) Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity. J Pharmacokinet Biopharm 15:473-496.
22. Narang RK, Mehta S, and Mathur VS (1977) Pharmacokinetic study of antipyrine in malnourished children. Am J Clin Nutr 30:1979-1982.
23. Parke DV and Ioannides C (1981) The role of nutrition in toxicology. Annu Rev Nutr 1:207-234.
24. Reich DL and Silvay G (1989) Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 36:186-197.
25. Reilly JJ, Weir J, McColl JH, and Gibson BE (1999) Prevalence of protein-energy malnutrition at diagnosis in children with acute lymphoblastic leukemia. J Pediatr Gastroenterol Nutr 29:194-197.
26. Ryder S, Way WL, and Trevor AJ (1978) Comparative pharmacology of the optical isomers of ketamine in mice. Eur J Pharmacol 49:15-23.
27. Sullivan DH, Sun S, and Walls RC (1999) Protein-energy undernutrition among elderly hospitalized patients: a prospective study. J Am Med Assoc 281:2013-2019.
28. Torún B and Chew F (1994) Protein-energy malnutrition, in Modern Nutrition in Health and Disease, vol. 2 (Shils ME, Olson JA, and Shike M eds) pp 950-976, Lea and Febiger, Philadelphia.
29. Trevor AJ, Woolf TF, Baillie TA, Adams JD, and Castagnoli N (1983) Stereoselective metabolism of ketamine enantiomers, in Phenycyclidine and Related Arylcyclohexylamines: present and Future Application (Kamenka JM, Domino EF, and Geneste P eds) pp 279-289, NPP Books, Ann Arbor.
30. Varma DR (1979) Influence of dietary protein on the anti-inflammatory and ulcerogenic effects and on the pharmacokinetics of phenylbutazone in rats. J Pharmacol Exp Ther 211:338-344.
31. Wagner BK and O'Hara DA (1997) Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. Clin Pharmacokinet 33:426-453.
32. Walter-Sack I and Klotz U (1996) Influence of diet and nutritional status on drug metabolism. Clin Pharmacokinet 31:47-64.
33. White PF, Schuttler J, Shafer A, Stanski DR, Horai Y, and Trevor AJ (1985) Comparative pharmacology of the ketamine isomers. Br J Anaesth 57:197-203.
34. White PF, Way WL, and Trevor AJ (1982) Ketamine-its pharmacology and therapeutic uses. Anesthesiology 56:119-136.
35. Wieber J, Gugler R, Hengstmann JH, and Dengler HJ (1975) Pharmacokinetics of ketamine in man. Anaesthesist 24:260-263.
36. Yanagihara Y, Kariya S, Ohtani M, Uchino K, Aoyama T, Yamamura Y, and Iga T (2001) Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 29:887-890.
37. Zhang W, Parentau H, Greenly RL, Metz CA, Aggarwal S, Wainer IW, and Tracy TS (1999) Effect of protein-calorie malnutrition on cytochromes P450 and glutathione S-transferase. Eur J Drug Metab Pharmacokinet 24:141-147.